-
1
-
-
84862646773
-
The red journal's top 10 most downloaded articles of 2011
-
Zietman AL. The Red Journal's Top 10 Most Downloaded Articles of 2011. Int J Radiat Oncol Biol Phys. 2012; 83(4):1073-1074.
-
(2012)
Int J Radiat Oncol Biol Phys.
, vol.83
, Issue.4
, pp. 1073-1074
-
-
Zietman, A.L.1
-
2
-
-
79959335126
-
70 gy versus 80 gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
-
Beckendorf V, Guerif S, Le Prisé E, et al. 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial. Int J Radiat Oncol Biol Phys. 2011; 80(4):1056-1063.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.80
, Issue.4
, pp. 1056-1063
-
-
Beckendorf, V.1
Guerif, S.2
Le Prisé, E.3
-
3
-
-
37049023209
-
Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer
-
Kuban DA, Tucker SL, Dong L, et al. Long-Term Results of the M.D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2008; 70(1):67-74.
-
(2008)
Int J Radiat Oncol Biol Phys.
, vol.70
, Issue.1
, pp. 67-74
-
-
Kuban, D.A.1
Tucker, S.L.2
Dong, L.3
-
4
-
-
78650804126
-
Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy
-
Martinez AA, Gonzalez J, Ye H, et al. Dose Escalation Improves Cancer-Related Events at 10 Years for Intermediate- and High-Risk Prostate Cancer Patients Treated With Hypofractionated High-Dose-Rate Boost and External Beam Radiotherapy. Int J Radiat Oncol Biol Phys. 2011; 79(2):363-370.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.79
, Issue.2
, pp. 363-370
-
-
Martinez, A.A.1
Gonzalez, J.2
Ye, H.3
-
5
-
-
79954420210
-
Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography
-
Barney BM, Lee RJ, Handrahan D, et al. Image-Guided Radiotherapy (IGRT) for Prostate Cancer Comparing kV Imaging of Fiducial Markers With Cone Beam Computed Tomography. Int J Radiat Oncol Biol Phys. 2011; 80(1):301-305.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.80
, Issue.1
, pp. 301-305
-
-
Barney, B.M.1
Lee, R.J.2
Handrahan, D.3
-
6
-
-
84855825726
-
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
-
King CR, Brooks JD, Gill H, et al. Long-Term Outcomes from a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2012; 82(2):877-882.
-
(2012)
Int J Radiat Oncol Biol Phys.
, vol.82
, Issue.2
, pp. 877-882
-
-
King, C.R.1
Brooks, J.D.2
Gill, H.3
-
7
-
-
81855203431
-
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?
-
Onishi H, Shirato H, Nagata Y, et al. Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non-Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery? Int J Radiat Oncol Biol Phys. 2011; 81(5): 1352-1358.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.81
, Issue.5
, pp. 1352-1358
-
-
Onishi, H.1
Shirato, H.2
Nagata, Y.3
-
8
-
-
79954414622
-
Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins?
-
Chan LW, Rabban J, Hwang ES, et al. Is Radiation Indicated in Patients With Ductal Carcinoma In Situ and Close or Positive Mastectomy Margins? Int J Radiat Oncol Biol Phys. 2011; 80(1):25-30.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.80
, Issue.1
, pp. 25-30
-
-
Chan, L.W.1
Rabban, J.2
Hwang, E.S.3
-
9
-
-
80255134559
-
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer
-
Koutcher L, Sherman E, Fury M, et al. Concurrent Cisplatin and Radiation Versus Cetuximab and Radiation for Locally Advanced Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys. 2011; 81(4): 915-922.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.81
, Issue.4
, pp. 915-922
-
-
Koutcher, L.1
Sherman, E.2
Fury, M.3
-
10
-
-
18544409287
-
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG9003
-
Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000; 48(1):7-16.
-
(2000)
Int J Radiat Oncol Biol Phys.
, vol.48
, Issue.1
, pp. 7-16
-
-
Fu, K.K.1
Pajak, T.F.2
Trotti, A.3
-
11
-
-
79952698481
-
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system
-
Levin VA, Bidaut L, Hou P, et al. Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System. Int J Radiat Oncol Biol Phys. 2011; 79(5):1487-1495.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.79
, Issue.5
, pp. 1487-1495
-
-
Levin, V.A.1
Bidaut, L.2
Hou, P.3
|